Biểu đồ giá cổ phiếu ABEO
ABEO Giá
Abeona Therapeutics Inc
$5.44
-1.44%
$-0.07
Khi đóng cửa: May 22, 16:00:00 GMT-4
$5.41
-0.55%
$-0.03
Phiên sau giờ: May 22, 20:00:00 GMT-4
Quay lại
Abeona Therapeutics Inc (ABEO) Giá
Thống kê chính
Giá đóng cửa trước
$5.52
Giá mở cửa
$5.58
Phạm vi ngày
$5.41 - $5.63
Phạm vi 52 tuần
$4 - $7.54
Khối lượng
657.6K
Khối lượng trung bình
1.2M
Tỷ suất cổ tức
--
EPS (TTM)
0.93
Vốn hóa thị trường
$308.6M
ABEO là gì?
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. The company is headquartered in Cleveland, Ohio and currently employs 226 full-time employees. The firm's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa. Its fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio serves as the manufacturing site for ZEVASKYN commercial production. Its development portfolio features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. Its AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases. Its pipeline programs include ABO-504 (Stargardt disease), ABO-503 (X-linked retinoschisis), ABO-505 (autosomal dominant optic atrophy), UX111 (Sanfilippo Syndrome Type A (MPS IIIA)), TSHA-102 (Rett Syndrome), and TSHA-118 (Infantile Batten Disease (CLN1 Disease)).
